SCHEMBL7048385

SCHEMBL7048385

CC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2ccc(Cl)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
SMPD1 P17405 4/20 0.55
NR4A2 P43354 1/20 0.53
HDAC1 Q13547 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
BCL2L1 Q07817 4/20 0.49
MCL1 Q07820 4/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
TSHR P16473 1/20 0.49
NR1H4 Q96RI1 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
POLB P06746 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7045371 0.93 KMT2A (0.62) MAOBMEN1KMT2ASMPD1NR4A2
SCHEMBL7048265 0.90 SMPD1 (0.60) MEN1KMT2ASMPD1HDAC1HDAC8
SCHEMBL7048541 0.89 NR4A1 (0.57) MAOBMEN1KMT2ASMPD1NR4A2
SCHEMBL7047622 0.88 MAOB (0.60) MAOBMEN1KMT2ASMPD1NR4A2
SCHEMBL7049348 0.87 MAOB (0.60) MAOAMAOBMEN1KMT2ABCL2L1
SCHEMBL7050091 0.86 MEN1 (0.50) MAOAMAOBMEN1KMT2ASMPD1
SCHEMBL7045567 0.86 MEN1 (0.60) MAOAMAOBMEN1KMT2ASMPD1
SCHEMBL7050697 0.86 SMPD1 (0.51) MAOAMAOBMEN1KMT2ASMPD1
SCHEMBL7052824 0.86 SMPD1 (0.62) MAOBMEN1KMT2ASMPD1NR4A2
SCHEMBL7045604 0.85 SMPD1 (0.61) MAOBMEN1KMT2ASMPD1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN MAOA 591/4885MAOB 396/4885MEN1 4502/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 MAOA 2901/4885MAOB 2736/4885MEN1 3302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.